New app aims to simplify insulin dosing for diabetes patients

NCT ID NCT06529705

Completed Disease control Sponsor: University Hospital, Montpellier Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested a mobile app called EkiYou V2 that helps people with diabetes figure out how much insulin to take. 21 adults who use multiple daily insulin injections used the app for 6 weeks. The goal was to see if the app safely improves blood sugar control and makes insulin dosing easier.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: EkiYou V2 mobile application
What this could lead to: If successful, this app could help people with diabetes better manage their insulin doses and improve blood sugar control without needing extra medication.
What could go wrong: This is a very small, early study with only 21 participants and no comparison group. The results may not apply to everyone, and the app might not work as well in real-world, long-term use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES TYPE 1 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES TYPE 1 DIABETES TYPE 2 ON INSULIN PANCREATOGENOUS DIABETES

Contacts and locations

Locations

Centre Hospitalier Universitaire de Montpellier

Montpellier, France, 34000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.